Tangzhiping Decoction Improves Glucose and Lipid Metabolism and Exerts Protective Effects Against White Adipose Tissue Dysfunction in Prediabetic Mice

References

• Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: the epidemiological evidence. Annu Rev Publ Health. 2021;42(1):59–77. doi:10.1146/annurevpublhealth-090419-102644
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed December 13, 2023.
   Google Scholar
• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Liu C, Foti K, Grams ME, Shin JI, Selvin E. Trends in self-reported prediabetes and metformin use in the USA: NHANES 2005–2014. J Gen Intern Med. 2020;35(1):95–101. doi:10.1007/s11606-019-05398-5
   PubMed Web of Science ®Google Scholar
• Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005–2016. JAMA Pediatr. 2020;174(2):e194498. doi:10.1001/jamapediatrics.2019.4498
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S. Diagnosis and management of prediabetes: a review. JAMA. 2023;329(14):1206–1216. doi:10.1001/jama.2023.4063
   PubMed Web of Science ®Google Scholar
• Tian J, Jin D, Bao Q, et al. Evidence and potential mechanisms of traditional Chinese medicine for the treatment of type 2 diabetes: a systematic review and meta-analysis. Diabetes Obe Metab. 2019;21(8):1801–1816. doi:10.1111/dom.13760
   PubMed Web of Science ®Google Scholar
• Chen LY, Zhou H, Gao YB. Traditional Chinese medicine syndrome differentiation of impaired glucose tolerance reduction. Chin J Basic Med Traditional Chin Med. 2007;13(3):223–224. doi:10.3969/j.issn.1006-3250.2007.03.026
   Google Scholar
• Gao YB, Zhou H, Zhao H, et al. Clinical research of traditional Chinese medical intervention on impaired glucose tolerance. Am J Chin Med. 2013;41(1):21–32. doi:10.1142/S0192415X1350002X
   PubMed Web of Science ®Google Scholar
• Zhu ZY, Gao YB, Liu J, et al. Impacts of Tangzhiping on glucose and insulin metabolism in the rats of insulin resistance. World J Integr Trad Western Med. 2015;4(12):1516–1518. doi:10.13935/j.cnki.sjzx.151111
   Google Scholar
• Gong X, Ji MY, Xu JP, Zhang CH, Li MH. Hypoglycemic effects of bioactive ingredients from medicine food homology and medicinal health food species used in China. Crit Rev Food Sci. 2020;60(14):2303–2326. doi:10.1080/10408398.2019.1634517
   PubMed Web of Science ®Google Scholar
• Wang HN, Xiang JZ, Qi Z, Du M. Plant extracts in prevention of obesity. Crit Rev Food Sci. 2022;62(8):2221–2234. doi:10.1080/10408398.2020.1852171
   PubMed Web of Science ®Google Scholar
• Li L, Li R, Zhu RY, et al. Salvianolic acid B prevents body weight gain and regulates gut microbiota and LPS/TLR4 signaling pathway in high-fat diet-induced obese mice. Food Funct. 2020;11(10):8743–8756. doi:10.1039/D0FO01116A
   PubMed Web of Science ®Google Scholar
• Raoufi S, Baluchnejadmojarad T, Roghani M, Ghazanfari T, Khojasteh F, Mansouri M. Antidiabetic potential of salvianolic acid B in multiple low-dose streptozotocin-induced diabetes. Pharm Biol. 2015;53(12):1803–1809. doi:10.3109/13880209.2015.1008148
   PubMed Web of Science ®Google Scholar
• Li D, Yang C, Zhu JZ, et al. Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3. Acta Pharmacol Sin. 2022;43(5):1285–1298. doi:10.1038/s41401-021-00736-y
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen ZT, Zhao XY, et al. Mechanisms of Kaempferol in the treatment of diabetes: a comprehensive and latest review. Front Endocrinol. 2022;13:990299. doi:10.3389/fendo.2022.990299
   PubMed Web of Science ®Google Scholar
• Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51–60. doi:10.1038/s41586-019-1797-8
   PubMed Web of Science ®Google Scholar
• Miao Z, Alvarez M, Ko A, et al. The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance. PLoS Genet. 2020;16(9):e1009018. doi:10.1371/journal.pgen.1009018
   PubMed Web of Science ®Google Scholar
• Morigny P, Boucher J, Arner P, Langin D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Rev Endocrinol. 2021;17(5):276–295. doi:10.1038/s41574-021-00471-8
   PubMed Web of Science ®Google Scholar
• Kusminski CM, Bickel PE, Scherer PE. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov. 2016;15(9):639–660. doi:10.1038/nrd.2016.75
   PubMed Web of Science ®Google Scholar
• Roumans KHM, Lindeboom L, Veeraiah P, et al. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nat Commun. 2020;511(1):1891. doi:10.1038/s41467-020-15684-0
   Google Scholar
• Singh RG, Yoon HD, Wu LM, Lu J, Plank LD, Petrov MS. Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta regression. Metabolism. 2017;69:1–13. doi:10.1016/j.metabol.2016.12.012
   PubMed Web of Science ®Google Scholar
• Longo M, Zatterale F, Naderi J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358. doi:10.3390/ijms20092358
   PubMed Web of Science ®Google Scholar
• Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549–1564. doi:10.1161/CIRCRESAHA.119.315896
   PubMed Web of Science ®Google Scholar
• Wu F, Shao Q, Xia Q, et al. A bioinformatics and Transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway. Phytomedicine. 2021;83:153487. doi:10.1016/j.phymed.2021.153487
   PubMed Web of Science ®Google Scholar
• Ma QL, Deng P, Lin M, et al. Long-term bisphenol A exposure exacerbates diet-induced prediabetes via TLR4-dependent hypothalamic inflammation. J Hazard Mater. 2021;402:123926. doi:10.1016/j.jhazmat.2020.123926
   PubMed Web of Science ®Google Scholar
• O’Brien PD, Guo K, Eid SA, et al. Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Dis Model Mech. 2020;13(2):dmm042101. doi:10.1242/dmm.042101
   PubMed Web of Science ®Google Scholar
• Rendell M. Pharmacotherapeutic options for prediabetes. Expert Opin Pharmaco. 2021;22(1):45–54. doi:10.1080/14656566.2020.1817381
   PubMed Web of Science ®Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. 3. Prevention or delay of type 2 diabetes and associated comorbidities: standards of care in diabetes-2023. Diabetes Care. 2023;46:S41–S48. doi:10.2337/dc22-S003
   PubMed Web of Science ®Google Scholar
• SinhaR, Ngo MD, Bartlett S, et al. Pre-Diabetes Increases Tuberculosis Disease Severity, While High Body Fat Without Impaired Glucose Tolerance Is Protective. Front Cell Infect Microbiol. 2021; 11; 691823. doi:10.3389/fcimb.2021.691823
   PubMed Web of Science ®Google Scholar
• Stenkula KG, Erlanson-Albertsson C. Adipose cell size: importance in health and disease. Am J Physiol-Reg I. 2018;315(2):R284–R295. doi:10.1152/ajpregu.00257.2017
   PubMed Web of Science ®Google Scholar
• Lin D, Xiao MS, Zhao J, et al. An overview of plant phenolic compounds and their importance in human nutrition and management of type 2 diabetes. Molecules. 2016;21(10):1374. doi:10.3390/molecules21101374
   PubMed Web of Science ®Google Scholar
• Rodriguez-Perez C, Segura-Carretero A, Del Mar Contreras M. Phenolic compounds as natural and multifunctional anti-obesity agents: a review. Crit Rev Food Sci. 2019;59(8):1212–1229. doi:10.1080/10408398.2017.1399859
   PubMed Web of Science ®Google Scholar
• Rahman N, Jeon M, Song HY, Kim YS. Cryptotanshinone, a compound of Salvia miltiorrhiza inhibits pre-adipocytes differentiation by regulation of adipogenesis-related genes expression via STAT3 signaling. Phytomedicine. 2016;23(1):58–67. doi:10.1016/j.phymed.2015.12.004
   PubMed Web of Science ®Google Scholar
• Wang J, Wang L, Lou GH, et al. Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol. 2019;57(1):193–225. doi:10.1080/13880209.2019.1577466
   PubMed Web of Science ®Google Scholar
• Fang JY, Huang TH, Chen WJ, Aljuffali IA, Hsu CY. Rhubarb hydroxyanthraquinones act as antiobesity agents to inhibit adipogenesis and enhance lipolysis. Biomed Pharmacother. 2022;146:112497. doi:10.1016/j.biopha.2021.112497
   PubMedGoogle Scholar
• Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16(2–3):97–110. doi:10.1016/j.phymed.2008.12.018
   PubMed Web of Science ®Google Scholar
• Wang L, Pydi SP, Zhu L, et al. Adipocyte G(i) signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity. Nat Commun. 2020;11(1):2995. doi:10.1038/s41467-020-16756-x
   PubMed Web of Science ®Google Scholar
• Davis JE, Braucher DR, Walker-Daniels J, Spurlock ME. Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes. J Nutr Biochem. 2011;22(2):136–141. doi:10.1016/j.jnutbio.2009.12.008
   PubMed Web of Science ®Google Scholar
• Chan PC, Liao MT, Lu CH, Tian YF, Hsieh PS. Targeting inhibition of CCR5 on improving obesity-associated insulin resistance and impairment of pancreatic insulin secretion in high fat-fed rodent models. Eur J Pharmacol. 2021;891:173703. doi:10.1016/j.ejphar.2020.173703
   PubMed Web of Science ®Google Scholar
• Kitade H, Sawamoto K, Nagashimada M, et al. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes. 2012;61(7):1680–1690. doi:10.2337/db11-1506
   PubMed Web of Science ®Google Scholar
• Xu MM, Zhou H, Hu P, et al. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning. Front Immunol. 2023;14:1084531. doi:10.3389/fimmu.2023.1084531
   PubMed Web of Science ®Google Scholar
• Del Cornò M, Varano B, Scazzocchio B, Filesi C, Masella R, Gessani S. Protocatechuic acid inhibits human dendritic cell functional activation: role of PPARγ up-modulation. Immunobiology. 2014;219(6):416–424. doi:10.1016/j.imbio.2014.01.007
   PubMed Web of Science ®Google Scholar
• Kim K, Kang JK, Jung YH, et al. Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver. Nat Commun. 2021;12(1):1822. doi:10.1038/s41467-021-22106-2
   PubMed Web of Science ®Google Scholar
• Ahmadian M, Duncan RE, Varady KA, et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes. 2009;58(4):855–866. doi:10.2337/db08-1644
   PubMed Web of Science ®Google Scholar
• Guo YY, Li BY, Xiao G, Liu Y, Guo L, Tang QQ. Cdo1 promotes PPARgamma-mediated adipose tissue lipolysis in male mice. Nat Metab. 2022;4(10):1352–1368. doi:10.1038/s42255-022-00644-3
   PubMedGoogle Scholar
• Li G, Li X, Yang L, et al. Adipose tissue-specific ablation of Ces1d causes metabolic dysregulation in mice. Life Sci Alliance. 2022;5(8). doi:10.26508/lsa.202101209
   Web of Science ®Google Scholar
• Fan C, Hu HT, Huang XY, et al. Betaine supplementation causes an increase in fatty acid oxidation and carbohydrate metabolism in livers of mice fed a high-fat diet: a proteomic analysis. Foods. 2022;11(6):881. doi:10.3390/foods11060881
   PubMed Web of Science ®Google Scholar
• Pandey GK, Vadivel S, Raghavan S, Mohan V, Balasubramanyam M, Gokulakrishnan K. High molecular weight adiponectin reduces glucolipotoxicity-induced inflammation and improves lipid metabolism and insulin sensitivity via APPL1-AMPK-GLUT4 regulation in 3T3-L1 adipocytes. Atherosclerosis. 2019;288:67–75. doi:10.1016/j.atherosclerosis.2019.07.011
   PubMed Web of Science ®Google Scholar